Ekaterina Troitskaya, NP
Nurse Practitioner · San Diego
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Scripps Health · 1,450 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ekaterina Troitskaya’s office at (858) 764-3000 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$146,083
Medicare paid this office $146,083 for 1,436 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 517 | $86,547 | $72 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 666 | $13,608 | $17 |
| Programming of dual lead pacemaker system | 170 | $10,090 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 476 | $10,078 | $18 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 153 | $6,605 | $38 |
See all 12 services
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 517 | $86,547 | $72 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 666 | $13,608 | $17 |
| Programming of dual lead pacemaker system | 170 | $10,090 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 476 | $10,078 | $18 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 153 | $6,605 | $38 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 174 | $4,174 | $21 |
| Programming of multiple lead implantable defibrillator system | 56 | $4,111 | $70 |
| Programming of dual lead implantable defibrillator system | 42 | $2,916 | $66 |
| Evaluation of implantable heart and blood vessel monitoring system | 63 | $2,073 | $32 |
| Programming of multiple lead pacemaker system | 30 | $1,922 | $62 |
| Programming of single lead pacemaker system | 38 | $1,903 | $49 |
| Evaluation of cardiac rhythm monitor system | 42 | $1,534 | $37 |
Who their Medicare patients are
1,436 Original Medicare patients in 2024. Average age 80 · Under 65 1% · 85 and older 28% · Women 44% · Also on Medicaid 6% · Health risk score 1.67. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 62% · Coronary heart disease 47% · Heart failure 42% · Chronic kidney disease 33% · Diabetes 24% · Depression 21% · Stroke 20% · Cancer 17% · COPD 17% · Dementia 10%.
The office billed $813,753, Medicare allowed $194,996 and paid $146,083; for 3,408 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,436 | 3,408 | 80 | 1.67 | $813,753 | $146,083 |
| 2023 | 852 | 2,060 | 79 | 1.64 | $258,316 | $52,225 |
| 2022 | 1,032 | 2,974 | 79 | 1.57 | $366,571 | $72,188 |
| 2021 | 101 | 157 | 79 | 1.51 | $32,106 | $6,249 |
| 2020 | 223 | 400 | 78 | 1.65 | $134,159 | $35,279 |
| 2019 | 78 | 118 | 76 | 1.20 | $23,336 | $7,202 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 343 | $18,365 | $42 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 416 | $8,802 | $20 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 359 | $8,282 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 271 | $5,772 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 137 | $3,461 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 121 | $2,228 | $17 |
| Programming of dual lead pacemaker system | 35 | $1,963 | $52 |
| Programming of multiple lead implantable defibrillator system | 19 | $1,394 | $73 |
| Programming of dual lead implantable defibrillator system | 11 | $740 | $67 |
2022: 12 services
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 611 | $17,231 | $22 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 286 | $16,376 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 384 | $10,483 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 209 | $7,413 | $27 |
| Programming of dual lead pacemaker system | 94 | $6,123 | $57 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 184 | $4,370 | $19 |
| Programming of multiple lead implantable defibrillator system | 36 | $3,371 | $75 |
| Programming of dual lead implantable defibrillator system | 17 | $1,553 | $74 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 21 | $1,201 | $24 |
| Programming of multiple lead pacemaker system | 15 | $1,080 | $68 |
| Evaluation of cardiac rhythm monitor system | 21 | $767 | $37 |
| Evaluation of implantable heart and blood vessel monitoring system | 21 | $766 | $35 |
2021: 4 services
| Programming of dual lead pacemaker system | 39 | $2,400 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 38 | $855 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 22 | $486 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $383 | $24 |
2020: 6 services
| Transitional care management services for problem of high complexity | 72 | $16,040 | $208 |
| Return visit (30+ min) | 90 | $7,182 | $71 |
| Transitional care management services for problem of at least moderate complexity | 20 | $3,380 | $161 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,021 | $55 |
| Short return visit (20+ min) | 29 | $1,897 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 58 | $855 | $14 |
2019: 4 services
| Return visit (30+ min) | 28 | $2,623 | $87 |
| Return visit (30+ min) | 22 | $1,672 | $56 |
| Short return visit (20+ min) | 16 | $960 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $183 | $14 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 17 Part D prescriptions in 2023. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 17 | None | 0% (0) | 0% | $137 |
| 2022 | 111 | 37 | 0% (0) | 10% | $11,077 |
| 2021 | 166 | 65 | 0% (0) | 10% | $16,085 |
| 2020 | 213 | 84 | 0% (0) | 10% | $24,116 |
| 2019 | 348 | 66 | 0% (0) | 16% | $40,230 |
| 2018 | 128 | 39 | 0% (0) | 17% | $14,865 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Amlodipine Besylate | 13 | $84 | $6 |
2022: 3 drugs
| Atorvastatin | 24 | $336 | $14 |
| Chlorthalidone | 11 | $163 | $15 |
| Amlodipine Besylate | 21 | $142 | $7 |
2021: 2 drugs
| Atorvastatin | 23 | $416 | $18 |
| Amlodipine Besylate | 29 | $268 | $9 |
2020: 7 drugs
| Diltiazem 24hr Er (Cd) | 13 | $800 | $62 |
| Amiodarone | 19 | $560 | $29 |
| Metoprolol | 15 | $309 | $21 |
| Hydralazine | 11 | $271 | $25 |
| Atorvastatin | 13 | $186 | $14 |
| Metoprolol | 13 | $67 | $5 |
| Lisinopril | 11 | $67 | $6 |
2019: 10 drugs
| Eliquis | 15 | $12,515 | $834 |
| Rosuvastatin | 16 | $1,032 | $65 |
| Atorvastatin | 30 | $517 | $17 |
| Diltiazem 24hr Er (Cd) | 13 | $462 | $36 |
| Metoprolol | 18 | $422 | $23 |
| Hydralazine | 23 | $388 | $17 |
| Carvedilol | 13 | $205 | $16 |
| Lisinopril | 17 | $122 | $7 |
| Torsemide | 11 | $105 | $10 |
| Amlodipine Besylate | 13 | $54 | $4 |
2018: 2 drugs
| Rosuvastatin | 22 | $1,334 | $61 |
| Atorvastatin | 11 | $225 | $20 |
Money from drug and device companies
$1,086 in 2025
| 2025 | 5 | 18 | None | $1,086 |
| 2024 | 3 | 5 | None | $265 |
| 2023 | 1 | 2 | $210 | $350 |
| 2021 | 4 | 7 | None | $241 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Impulse Dynamics (USA) | Optimizer | $464 | 7 payments
|
| Medtronic | Linq II | $357 | 7 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $173 | 1 payment
|
| Boston Scientific | S-Icd System Magnet | $74 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 1 payment
|
See all 18 published payments
| Impulse Dynamics (USA) | Meals · 2025-12-19 | Optimizer | $75 |
| Impulse Dynamics (USA) | Meals · 2025-11-19 | Optimizer | $113 |
| Impulse Dynamics (USA) | Meals · 2025-11-03 | Optimizer | $34 |
| Boston Scientific | Meals · 2025-10-29 | S-Icd System Magnet | $42 |
| Impulse Dynamics (USA) | Meals · 2025-10-14 | Optimizer | $35 |
| Impulse Dynamics (USA) | Meals · 2025-10-06 | Optimizer | $68 |
| Edwards Lifesciences | Meals · 2025-09-30 | Sapien 3 Ultra Resilia | $173 |
| Impulse Dynamics (USA) | Meals · 2025-09-08 | Optimizer | $59 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-22 | Lifevest | $18 |
| Impulse Dynamics (USA) | Meals · 2025-06-26 | Optimizer | $81 |
| Medtronic | Meals · 2025-04-24 | None | $37 |
| Medtronic | Meals · 2025-04-24 | None | $65 |
| Medtronic | Meals · 2025-04-24 | None | $73 |
| Medtronic | Meals · 2025-04-23 | None | $19 |
| Medtronic | Meals · 2025-04-23 | None | $135 |
| Medtronic | Meals · 2025-02-25 | Linq II | $21 |
| Medtronic | Meals · 2025-02-14 | Linq II | $8 |
| Boston Scientific | Meals · 2025-02-11 | Resonate El Icd Vr | $32 |
See earlier years (2024, 2023, 2021)
2024: $265
| Impulse Dynamics (USA) | Optimizer | $148 | 2 payments
|
| Medtronic | Linq II | $77 | 2 payments
|
| Scpharmaceuticals | Furoscix | $40 | 1 payment
|
2023: $350
| Medtronic | Micra | $350 | 2 payments
|
2021: $241
| AstraZeneca Pharmaceuticals LP | Farxiga | $131 | 2 payments
|
| Pfizer | Eliquis | $72 | 3 payments
|
| Esperion Therapeutics | Nexletol | $24 | 1 payment
|
| Amgen | Repatha | $15 | 1 payment
|
Professional record
- NPI
- 1174037451
- Licence
- CA NP95007663
- Group
- Scripps Health
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-11-26
- NPI last updated
- 2019-10-07
This is when the NPI record was last certified, not a medical board exam.